Jonathan Goodman, MPhil

Jonathan Goodman, MPhil, is the Editor of Cancer Therapy Advisor.

Most Recent Articles by Jonathan Goodman, MPhil

Durable Tumor Response Seen in Some Lymphomas With Tazemetostat

Durable Tumor Response Seen in Some Lymphomas With Tazemetostat

By

Tazemetostat demonstrated preclinical activity against EZH2­-mutant non-Hodgkin lymphomas.

Dual Inhibitor for Treating CLL/SLL, Follicular Lymphoma Granted Priority Review

Dual Inhibitor for Treating CLL/SLL, Follicular Lymphoma Granted Priority Review

By

Duvelisib, a first-in-class dual inhibitor of PI3K-delta and -gamma, was evaluated in patients with relapsed/refractory CLL/SLL and in patients with refractory indolent non-Hodgkin lymphoma.

Outcomes for Elderly With Hematologic Cancers Effected by Cognitive Impairments

Outcomes for Elderly With Hematologic Cancers Effected by Cognitive Impairments

By

Study data suggest that cognitive impairments may be associate with worse survival among patients with hematologic cancer.

Adding Trastuzumab to Uterine Serous Carcinoma Treatment Extended PFS

Adding Trastuzumab to Uterine Serous Carcinoma Treatment Extended PFS

By

Researchers explored whether adding trastuzumab to carboplatin and paclitaxel would improve survival outcomes for patients with advanced/recurrent disease with overexpressed HER2/neu.

Direct-to-Consumer Genetic Test for Select <i>BRCA</i> Mutations Gets FDA Nod

Direct-to-Consumer Genetic Test for Select BRCA Mutations Gets FDA Nod

By

The US FDA has approved a consumer test that may indicate increased breast and ovarian cancer risk in some individuals.

More Articles by Jonathan Goodman, MPhil

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs